參考文獻/References:
[1] Barras M A,Kirkpatrick C M J,Green B.Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey [J].British Journal of Clinical Pharmacology,2010,69(5): 520-528.
[2] Pourghaznein T,Azimi A V,Jafarabadi M A.The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin[J].Journal of Clinical Nursing,2013,49(3):12-22.
[3] Chan H.Effects of injection duration on site pain intensity and bruising as sociated with subcutaneous heparin [J].J Adv Nurs,2001,35(6):882-892.
[4] 張菊霞,馬玉霞,溫玉潔,等.皮下注射低分子肝素時不同推注時間對皮下出血的影響[J].中華護理雜志,2014,49(2): 233-235.
[5] McConnell E A.Dos & donts:administering subcutaneous heparin[J].Nursing,2000,30:17-18.
[6] 耿洪業(yè).實用內(nèi)科藥物治療學[M].北京:人民衛(wèi)生出版社,2000:340.
[7] 高戈,高春華.磺達肝葵鈉和低分子肝素致皮下出血臨床觀察[J].實用藥物與臨床,2012,15(1):57-58.
[8] 高亞莉.低分子肝素注射方法的改進對皮下出血的影響[J].中華全科醫(yī)學,2013,11(9):1491-1492.
[9] 張柱花.酚妥拉明與低分子肝素鈣聯(lián)用治療肺心病的臨床效果觀察[J].臨床研究,2018,26(1):125-127.
[10] 金歌,屈清榮,王俊平,等.皮下注射低分子肝素優(yōu)勢方案研究[J].護理學雜志,2016,31(9): 55-57.